Back to Search
Start Over
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility
- Source :
- Future Microbiology, 14(4), 267-274. Future Medicine Ltd., Future Microbiology
- Publication Year :
- 2019
-
Abstract
- Aim: Presenting the first clinical case of Wickerhamomyces myanmarensis. Patients & methods: Yeast cells were isolated from blood and central venous catheter of a 5.5-year-old male subject. API 20C AUX, MALDI-TOF MS, ITS and LSU rDNA sequencing, and our qPCR assay were used for identification and the MIC values were determined by CLSI M27-A3. Results: ITS and LSU rDNA sequencing identified both isolates as W. myanmarensis, while API 20C AUX and MALDI-TOF MS did not identify them correctly. Our qPCR specifically distinguished W. myanmarensis from W. anomalus. Isolate obtained from blood showed a higher MIC value for fluconazole, voriconazole and posaconazole. Conclusion: Utilization of reliable identification tools might reveal the genuine spectrum of opportunistic yeast species.
- Subjects :
- Male
0301 basic medicine
Microbiology (medical)
Posaconazole
Antifungal Agents
030106 microbiology
central venous catheter
Microbial Sensitivity Tests
Biology
Real-Time Polymerase Chain Reaction
specific multiplex qPCR
Microbiology
DNA sequencing
law.invention
03 medical and health sciences
Wickerhamomyces
Drug Resistance, Fungal
blood
law
medicine
Humans
Case Series
Multiplex
Child
Fluconazole
Fungemia
Polymerase chain reaction
Voriconazole
antifungal susceptibility testing
Triazoles
medicine.disease
Wickerhamomyces myanmarensis
3. Good health
030104 developmental biology
Saccharomycetales
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 17460913
- Database :
- OpenAIRE
- Journal :
- Future Microbiology, 14(4), 267-274. Future Medicine Ltd., Future Microbiology
- Accession number :
- edsair.doi.dedup.....db8bb67ecdd93268db38a3c99018ecda